Clinical Trial Update: VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the DNA vaccine VGX-3100 delivered by electroporation in HIV-positive individuals with high-grade anal intraepithelial neoplasia has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Intraepithelial Neoplasia High-grade
• Human Immunodeficiency Virus Infection
• Human Papillomavirus Infection

Drugs mentioned

• VGX-3100

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Anal Intraepithelial Neoplasia, High Grade Squamous Intraepithelial Neoplasia | Phase 2 | Status: COMPLETED